ClinicalTrials.Veeva

Menu

The Efficacy and Safety of Repeat-dose Potenfill for Temporary Penile Enhancement

Medytox logo

Medytox

Status

Completed

Conditions

Penile Girth Enhancement
Penile Enhancement

Treatments

Device: Potenfill

Study type

Interventional

Funder types

Industry

Identifiers

NCT03840070
MT05-KR18PGE1005

Details and patient eligibility

About

This clinical study is for small-penis syndrome males who have previously been treated with hyaluronic acid filler for the purpose of increasing their penis.

This study will determine the long-term efficacy and safety of Potenfill.

Enrollment

20 patients

Sex

Male

Ages

19 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Male subjects aged above 19 and below 65. (20≤male≥65)
  • Subjects will sign an informed consent form

Exclusion criteria

  • Prior treatment for penile enhancement (e.g. fat, dermal graft).
  • Allergic to hyalluronic acid.

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

20 participants in 1 patient group

Potenfill
Experimental group
Treatment:
Device: Potenfill

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems